Denmark vs IDA only: Access to anti-retroviral drugs, male
Denmark
93.0%
in 2023
IDA only
80.4%
in 2024
Denmark rank
7th
IDA only rank
4th
Access to anti-retroviral drugs, male over time
- Denmark
- IDA only
How they compare
Denmark currently reports 93.0% against 80.4% in IDA only, a difference of 12.6%.
That makes Denmark's figure about 1.2 times IDA only's.
Across all 24 years both countries report, Denmark has been ahead every year.
Denmark ranks 7th and IDA only ranks 4th of 141 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | IDA only | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.4% | 5.7% | 43.7% | Denmark |
| 2010s | 77.6% | 39.9% | 37.7% | Denmark |
| 2020s | 91.2% | 71.1% | 20.2% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Denmark or IDA only?
- Denmark, at 93.0% against 80.4% in IDA only as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Denmark and IDA only?
- 12.6%, with Denmark ahead.
- How many years of comparable data are there for Denmark and IDA only?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and IDA only rank globally for access to anti-retroviral drugs, male?
- Denmark ranks 7th and IDA only ranks 4th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.